Related Experiment Videos
[Life expectancy in acquired vitium cordis after operative treatment (author's transl)]
Insights
Timely surgical treatment for acquired heart diseases, including valve defects and coronary heart disease, offers significant benefits with low risks. Early intervention is key for successful outcomes and improved quality of life.
Area of Science:
- Cardiovascular Surgery
- Cardiac Valve Repair and Replacement
- Coronary Artery Bypass Grafting
Context:
- Review of surgical outcomes for over 1500 heart valve operations and 800 coronary surgical procedures.
- Analysis of acquired heart disease treatment efficacy and patient recovery.
- Established surgical experience in complex cardiac interventions.
Purpose:
- To present the indications and results of operative treatments for acquired heart diseases.
- To evaluate the success rates and risks associated with prosthetic valve substitution.
- To assess the benefits of surgical intervention for coronary heart disease compared to conservative management.
Summary:
- Prosthetic substitution for aortic and mitral defects shows a risk of less than 5% when performed timely and before irreversible changes occur.
- Surgical treatment for coronary heart disease is superior to conservative therapy, with a risk under 2% under strict indications.
- Timely surgery for segmental stenoses prevents myocardial fibrosis, with 70% of patients experiencing temporary freedom from symptoms after palliative operations.
Impact:
- Highlights the effectiveness of early surgical intervention in managing acquired heart conditions.
- Provides evidence for improved patient outcomes and quality of life through cardiac surgery.
- Emphasizes the importance of timely surgical decisions to prevent disease progression and irreversible damage.
Abstract:
Indications and results of operative treatment of acquired heart diseases are presented with reference to our experience with over 1500 operations on the heart valves and over 800 coronary surgical operations. The risk in timely operation for prosthetic substitution of aortic and mitral defects is less than 5%. An essential condition is, however, that no irreversible changes have developed and that the defect could be completely corrected. Surgical treatment of coronary heart disease is superior to conservative therapy and carries a risk of under 2% on strict indication. Timely operation on segmental stenoses before the ischemic myocardium is fibrosed is an essential. 70% of patients operated on can count on freedom from complaint for the time being after these palliative operations.